![](/img/cover-not-exists.png)
Zoledronic acid improves clinical outcomes in patients with bone metastatic hormone-naive prostate cancer in a multicenter clinical trial.
Okegawa, Takatsugu, Higaki, Masao, Matsumoto, Tetsuo, Kase, Hiroshi, Murata, Akihiro, Noda, Kenjiro, Noda, Haruhisa, Asaoka, Hiroshi, Oshi, Masaya, Tomoishi, Junzo, Uchida, Hiroji, Higashihara, Eiji,Volume:
34
Year:
2014
Language:
english
Journal:
Anticancer research
DOI:
10.0000/PMID25075079
File:
PDF, 117 KB
english, 2014